Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Norway

 

Norway plans national high-throughput genome sequencing platform

Norway is quietly doing something unusual with genetics. A bunch of academics and medical boffins are trying to figure out how to build a high-throughput genome sequencing (HTS) platform that serves the entire national population. The project is called the Norwegian Genetic Analysis Platform (NGAP), and is under development co-operatively by Oslo University and Oslo University Hospital. What are the implications of this for healthcare systems?

New boss for Unilabs

Jos Lamers, former CEO of Nucletron, has replaced Jean-Paul Rigaudeau as CEO of Unilabs, the international lab and imaging chain. Lamers nearly took the same position at imaging group Euromedic a year ago.

Curato sold to Altor

Norwegian imaging services provider Curato has been sold by Capman to Altor Equity Partners, following the election victory of the right in early September 2013. Why would Altor invest in a company whose sales have all but flat-lined for four years?

Danish primary care market to open in 2014

Denmark is set to massively liberalise its primary care sector. This comes after a ground-breaking primary and outpatient care contract, worth DKK 200m (€26.82m) per annum, was successfully tendered by the Sjaelland region in May 2013 and won by Aleris. Is Denmark set to follow Sweden in creating an active role for the private sector? Falck thinks so: the emergency services and clinic provider has just acquired medical recruitment company Skandinavisk Halsovard. We talk to CEO of Falck’s healthcare services division Jan Steenhard, Skandinavisk’s continuing Director Borje Eriksson and former Global Health Partner and Capio CEO Per Batelson.

FREE BLOG Finding public pressure points

Could recruitment be a way into public healthcare systems for private providers? Falck has bet on peripheral services - ambulance provision and recruitment - as a way to build relationships with Nordic healthcare systems. Can providers elsewhere do the same?

Healthcare Reform – Opportunity or Threat? Presentation, Nicolaus Henke, Global Leader of the Healthcare Systems and Services Practice, McKinsey

Nicolaus has unrivaled access to, and experience of, European payors. He examines the reform trajectory and likely budget growth in different European countries and considers what impact this will have for private hospitals, outsourcers and specialist service providers. Presented at the Healthcare Europa Annual Conference 2013, New Models for Challenging Times.

Opportunity knocks if Norway moves right

One of the few countries not moving to the left in Europe is wealthy Norway, where the Red/Green alliance is likely to lose the autumn 2013 general election after a decade in power. The right wants to push patient choice. So what would this mean for Norwegian private healthcare?

The good, the bad and the ugly

The health systems of the OECD have been ranked. The winners: France, Finland, Norway and Sweden. The losers: Germany, Switzerland, Ireland, Austria and the Czech Republic. We talk to Eric N. Tchouaket, principal author of the academic ranking study, to find out what this tells us about these health systems.

The rise of home dialysis and how it will affect the dialysis market in Europe

Home dialysis can cost as little as half the price of in-centre treatment and is often preferred by patients. We talk to Eero Hokinen of Helsinki University Hospital and Dr. Wim van Biesen at Ghent University Hospital about why only 11% of European dialysis patients get treatment at home and where the market will go.

Find Us